Trials / Active Not Recruiting
Active Not RecruitingNCT07276776
An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Insulet Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 participants completing the 6-week treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Omnipod M system | The Omnipod M system will allow user to use a lower glucose target and improve systems glucose control |
Timeline
- Start date
- 2025-12-12
- Primary completion
- 2026-03-30
- Completion
- 2026-03-30
- First posted
- 2025-12-11
- Last updated
- 2026-03-31
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07276776. Inclusion in this directory is not an endorsement.